Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP
- 18 October 2025
- journal article
- practice guideline
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 72 (9) , 501639
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts françaisMédecine des Maladies Métaboliques, 2024
- Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetesDiabetologia, 2024
- Utility of genetic risk scores in type 1 diabetesDiabetologia, 2023
- Immunological biomarkers for the development and progression of type 1 diabetesDiabetologia, 2018
- Type 1 diabetesThe Lancet, 2018
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in ChildrenJAMA, 2013
- An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of ageDiabetologia, 2011
- Life table analysis of the risk of Type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markersDiabetologia, 1992
- A Prospective Study of the Development of Diabetes in Relatives of Patients with Insulin-Dependent DiabetesNew England Journal of Medicine, 1990
- PREDICTING INSULIN-DEPENDENT DIABETESThe Lancet, 1988